Hodgkin lymphoma
Classical and nodular lymphocyte-predominant forms are evaluated and treated according to stage and risk.
Hodgkin and non-Hodgkin lymphoma
Lymphoma Treatment in Turkey
Information about lymphoma treatment in Turkey, including biopsy review, exact subtype classification, PET-CT staging, systemic therapies, radiotherapy, transplant, medical records, and costs.
Biopsy-based diagnosisA tissue sample is central to defining most lymphoma subtypes.
Structured stagingImaging and clinical findings show the extent of disease.
Specialist treatment planningHematology, pathology, radiology, and transplant teams may collaborate.
What to know
Lymphoma is a broad group of cancers with many distinct subtypes
Lymphoma begins in cells of the lymphatic system. The two broad groups are Hodgkin lymphoma and non-Hodgkin lymphoma, but each includes different diseases with different growth rates and treatment approaches.
An adequate biopsy is important because treatment is chosen according to the precise subtype. Imaging, blood tests, bone marrow testing in selected cases, and molecular or genetic studies may also be required.
Conditions and clinical areas
Lymphoma subtypes commonly managed by specialist teams
The biological behavior ranges from slowly growing indolent lymphomas to aggressive diseases that require prompt treatment.
Diffuse large B-cell lymphoma
An aggressive non-Hodgkin lymphoma that usually requires prompt systemic treatment.
Follicular lymphoma
An indolent B-cell lymphoma that may be observed or treated according to symptoms and disease burden.
Mantle cell lymphoma
A B-cell lymphoma requiring subtype, stage, molecular, and patient-fitness assessment.
T-cell lymphomas
A diverse group of less common lymphomas requiring specialized pathology and treatment planning.
Relapsed or refractory lymphoma
Further treatment may include alternative systemic therapy, transplant, CAR T-cell therapy, or clinical trials for selected patients.
Diagnosis and evaluation
Tests used to diagnose and stage lymphoma
Accurate pathology and staging are essential because treatment differs significantly between subtypes.
Lymph-node or tissue biopsy
Excisional or core biopsy provides tissue for morphology, immunohistochemistry, flow cytometry, and molecular tests.
PET-CT and other imaging
Imaging helps determine disease distribution, stage, treatment planning, and response.
Blood and selected marrow tests
Blood counts, organ function, viral screening, and sometimes bone marrow assessment support staging and treatment preparation.
Possible treatment approaches
Lymphoma treatment depends on subtype, stage, and response
Treatment may include observation, systemic therapy, radiotherapy, cellular therapy, or transplantation.
Active surveillance
Some indolent lymphomas without symptoms may be monitored until treatment is needed.
Chemotherapy and immunochemotherapy
Drug combinations, often including an antibody, are used for many Hodgkin and non-Hodgkin lymphomas.
Targeted therapy
Selected medicines act on specific pathways or surface proteins in lymphoma cells.
Radiation therapy
Radiotherapy may be used for localized disease, combined treatment, or symptom control.
CAR T-cell and cellular therapy
For selected relapsed or refractory B-cell lymphomas, cellular therapy may be considered.
Stem cell transplantation
Autologous or allogeneic transplant may be used in selected high-risk or relapsed cases.
Medical records
Records useful for a lymphoma review
The pathology material and treatment-response information are especially important.
Clinical summarySymptoms, diagnosis date, stage, previous treatment, response, and current condition.
Biopsy and pathologyOriginal pathology report, immunohistochemistry, flow cytometry, molecular tests, and slide or block availability.
PET-CT and CT imagingWritten reports and original DICOM files from staging and response assessments.
Laboratory resultsBlood counts, LDH, kidney and liver function, viral screening, and other relevant tests.
Treatment protocolsDrug names, doses, cycle dates, radiotherapy summary, and treatment complications.
Transplant or cellular therapy recordsPrevious stem cell collection, transplant, CAR T-cell therapy, or donor information if applicable.
Specialist departments
Specialists involved in lymphoma care
Treatment planning may require hematology, hematopathology, imaging, radiation oncology, transplant, and supportive care.
Lymphoma hematology
Directs subtype-specific systemic treatment and response monitoring.
Hematopathology
Confirms the exact lymphoma subtype using tissue, immunohistochemistry, and molecular tools.
Nuclear medicine and radiology
Performs PET-CT and other imaging for stage and response assessment.
Radiation oncology
Plans radiotherapy when it is appropriate for the subtype and stage.
Transplant and cellular therapy
Evaluates autologous or allogeneic transplant and CAR T-cell therapy for selected patients.
Infectious and supportive care
Manages infection risk, blood counts, symptoms, and treatment complications.
Treatment cost in Turkey
Lymphoma cost depends on subtype, treatment, and response
The cost differs between observation, outpatient treatment, intensive systemic therapy, radiotherapy, transplantation, and cellular therapy. Pathology review and PET-CT may also be important components. More general information is available on the treatment pricing page.
- Hodgkin or non-Hodgkin lymphoma subtype and stage
- Biopsy review, immunohistochemistry, and molecular tests
- PET-CT and response assessments
- Number and type of systemic treatment cycles
- Radiotherapy, transplant, or cellular therapy when indicated
Frequently asked questions
Answers before sending medical records
Is biopsy necessary to diagnose lymphoma?
In most cases, tissue is needed to determine whether lymphoma is present and to classify the exact subtype. Imaging alone cannot provide a complete diagnosis.
What is the difference between Hodgkin and non-Hodgkin lymphoma?
They are broad groups defined by pathology. Non-Hodgkin lymphoma includes many B-cell and T-cell subtypes with different behavior and treatment.
Why is PET-CT used?
For many lymphomas, PET-CT helps determine disease extent and evaluate response, but its use depends on the subtype and clinical situation.
Can pathology be reviewed before travel?
Often yes. The hospital may review reports first and then request slides, blocks, or additional testing.
Is every lymphoma treated immediately?
Some indolent lymphomas can be monitored when there are no treatment indications; aggressive lymphomas often require prompt therapy.
When are transplant or CAR T-cell therapy considered?
They may be options for selected relapsed, refractory, or high-risk lymphomas after specialist assessment.
Can the cost be estimated in advance?
A preliminary estimate is possible after pathology, stage, previous treatment, and the proposed plan are reviewed.
What symptoms require urgent local care?
Breathing difficulty, rapidly enlarging neck or chest swelling, severe weakness, high fever, bleeding, or sudden deterioration requires urgent local assessment.
Contact Medicina Turkey
Do you need information about lymphoma treatment in Turkey?
Send the pathology report, available biopsy information, PET-CT or CT files, treatment history, latest blood tests, and your main question.
Medical sources:
- National Cancer Institute — Lymphoma
- National Cancer Institute — Hodgkin Lymphoma Treatment
- National Cancer Institute — Non-Hodgkin Lymphoma Treatment
- National Cancer Institute — Lymphoma Research
This page provides general educational information and does not replace a medical examination, diagnosis, or individualized treatment plan. Treatment options and outcomes vary according to the clinical situation.